Asthma and COPD - The C/EBP Connection

Nicola Miglino, Michael Roth, Michael Tamm, Peter Borger*
Pulmonary Cell Research, Departments of Biomedicine and Pneumology, University Hospital Basel, Switzerland

Article Metrics

CrossRef Citations:
Total Statistics:

Full-Text HTML Views: 3316
Abstract HTML Views: 2083
PDF Downloads: 688
Total Views/Downloads: 6087
Unique Statistics:

Full-Text HTML Views: 1549
Abstract HTML Views: 1208
PDF Downloads: 473
Total Views/Downloads: 3230

Creative Commons License
© Miglino et al.; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the Pulmonary Cell Research, University of Basel, Department of Biomedicine, Hebelstrasse 20, CH - 4031 Basel, Switzerland; Tel: +61 41 265 3254; Fax: +61 41 265 2350; E-mail:


Asthma and chronic obstructive pulmonary disease (COPD) are the two most prominent chronic inflammatory lung diseases with increasing prevalence. Both diseases are associated with mild or severe remodeling of the airways. In this review, we postulate that the pathologies of asthma and COPD may result from inadequate responses and/or a deregulated balance of a group of cell differentiation regulating factors, the CCAAT/Enhancer Binding Proteins (C/EBPs). In addition, we will argue that the exposure to environmental factors, such as house dust mite and cigarette smoke, changes the response of C/EBPs and are different in diseased cells. These novel insights may lead to a better understanding of the etiology of the diseases and may provide new aspects for therapies.

Keywords: Asthma, COPD, airway inflammation, airway wall remodelling, CCAAT-enhancer binding proteins..